Theranos Lab Practices Pose Immediate Jeopardy To Patient Health: US Regulators

U.S. regulators sent a letter to Theranos Inc., saying its Newark, California facility has deficient lab practices. The non-compliance of the lab is said to pose immediate jeopardy to patient safety.